What is the role of PFTs in monitoring adverse effects of surgery, drug treatments, radiation therapy, and during hospitalization?

Respiratory Care

Volumn 57, Issue 1, 2012, Pages 75-84

  Hnatiuk, Oleh W ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Clinical utility; Outcomes; Pulmonary function testing; Risk

Indexed keywords

FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG FUNCTION TEST; LUNG SURGERY; LUNG TRANSPLANTATION; PATIENT MONITORING; PHYSICAL EXAMINATION; PREOPERATIVE EVALUATION; RESPIRATORY CARE; REVIEW; RISK ASSESSMENT; SPIROMETRY; SURGICAL RISK; TREATMENT PLANNING;

ALGORITHMS; DECISION MAKING; HOSPITALIZATION; HOSPITALS; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SPIROMETRY;

EID: 84856778856     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01467     Document Type: Review

References (40)

1. Hayhurst MD. Preoperative pulmonary function testing. Respir Med 1993;87(3):101-103.
2. Colice GL, Shafazarand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidence-based clinical practice guidelines, 2nd edition. Chest 2007;132(3 Suppl):161S-177S.
3. Armstrong P, Congleton J, Fountain SW, Jagoe T, McAuley DF, MacMahon J, et al; British Thoracic Society and Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. Guidelines on the selection of patients with lung cancer for surgery. Thorax 2001;56(2):89-108.
4. Miller JI Jr. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg 1993;105(2):347-351.
5. DeCamp MM Jr, Lipson D, Krasna M, Minai OA, McKenna RJ Jr, Thomashow BM. The evaluation and preparation of the patient for lung volume reduction surgery. Proc Am Thorac Soc 2008;5(4):427-431.
6. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345(15):1075-1083.
7. Fishman A, Martinez F, Naunheim K, Piantodosi S, Wise R, Ries A, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21):2059-2073.
8. Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006;144(8):581-595.
9. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006;144(8):575-580.
10. Wolkowicz J, Sturgeon J, Rawji M, Chan CK. Bleomycin-induced pulmonary function abnormalities. Clin Chest Med 1992;101(1):97-101.
11. Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RJ, Prosnitz LR. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002;94(11):2821-2829.
12. Lucraft HH, Wilkinson PM, Stretton TB, Read G. Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma. Eur J Cancer Clin Oncol 1982;18(2):133-139.
13. Van Barneveld PW, van der Mark TW, Sleijfer DT, Mulder NH, Koops HS, Sluiter HJ, Peset R. Predictive factors for bleomycininduced pneumonitis. Am Rev Respir Dis 1984;130(6):1078-1081.
14. Bell MR, Meredith DJ, Gill PG. Role of carbon monoxide diffusing capacity in the early detection of major bleomycin-induced pulmonary toxicity. Aust N Z J Med 1985;15(2):235-240.
15. Tsougos I, Nilsson P, Theodorou K, Kjellen E, Ewers SB, Jarlman O, et al. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol 2007;52(4):1055-1073.
16. Vagane R, Bruland OS, Fossa SD, Olsen DR. Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation. Acta Oncol 2008;47(2):248-254.
17. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(Suppl):S221-S247.
18. Centers for Disease Control and Prevention. Number of discharges from short-stay hospitals by first-listed diagnosis and age: United States, 2007. http://www.cdc.gov/nchs/data/nhds/3firstlisted/2007first3_numberage.pdf. Accessed October 31, 2011.
19. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al; Infectious Disease Society of America; American Thoracic Society. IDSA/ATS consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-S72.
20. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.
21. The Global Initiative for Chronic Obstructive Lung Disease. http://www.goldcopd.org. Accessed October 31, 2011.
22. Lodewijckx C, Sermeus W, Vanhaecht K, Panella M, Deneckere S, Leigheb F, Decramer M. Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. J Eval Clin Pract 2009;15(6):1101-1110.
23. The Global Initiative for Asthma. http://www.ginasthma.org. Accessed October 31, 2011.
24. US Department of Health & Human Services; National Heart, Lung and Blood Institute. Guidelines for the diagnosis and management of asthma (EPR-3). http://www.nhlbi.nih.gov/guidelines/asthma. Accessed October 31, 2011.
25. Fitzgerald JM, O'Byrne PM, McFetridge JT, Demuth D, Allen-Ramey FC. Pulmonary function testing in the emergency department and medications prescribed at discharge: results of the Multinational Acute asthma Management, Burden, and Outcomes (MAMBO) study. Prim Care Respir J 2010;19(2):155-162.
26. Yawn BP, Enright PL, Lemanske RF Jr, Israel E, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007;132(4):1162-1168.
27. Dales RE, Vandemheen KL, Clinch J, Aaron SD. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest 2005;128(4):2443-2447.
28. MacIntyre NR, Selecky PA. Is there a role for screening spirometry? Respir Care 2010;55(1):35-42.
29. Benumof JL, Alfery DD. Anesthesia for thoracic surgery. In: Miller RD, editor. Anesthesia, 4th edition. New York: Churchill Livingstone; 1994:970.
30. Eisenkraft JB, Cohen E, Neustein SM. Anesthesia for thoracic surgery. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia, 3rd edition. Philadelphia: Lippincott-Raven; 1997:790.
31. Neuman GG, Weingarten AE, Abramowitz RM, Kushins LG, Abramson AL, Ladner W. The anesthetic management of the patient with an anterior mediastinal mass. Anesthesiology 1984;60(2):144-147.
32. Hnatiuk OW, Corcoran PC, Sierra A. Spirometry in surgery for anterior mediastinal masses. Chest 2001;120(4):1152-1156.
33. Egan TM, Kotloff RM. Pro/con debate: lung allocation should be based on medical urgency and transplant survival and not on waiting time. Chest 2005;128(1):407-415.
34. US Department of Health & Human Services; Health Resources and Services Administration; Organ Procurement and Transplantation Network. http://optn.transplant.hrsa.gov. Accessed October 31, 2011.
35. Egan TM, Bennett LE, Garrity ER, Grover FL, Ring WS, Robbins RC, et al. Predictors of death on the UNOS lung transplant waiting list: results of a multivariate analysis. J Heart Lung Transplant 2001;20(2):242.
36. Egan TM, Bennett LE, Garrity ER, Grover FL, et al. Are there predictors of death at the time of listing for lung transplant. J Heart Lung Transplant 2002;21(1):154.
37. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris J, Egan JJ, et al. International Guidelines for the selection of lung transplant candidates: 2006 update. A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-755.
38. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity Index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
39. Imfeld S, Bloch KE, Weder W, Russi EW. The BODE index after lung volume reduction surgery correlates with survival. Chest 2006;129(4):873-878.
40. Lahzami S, Bridevaux PO, Soccal PM, Wellinger J, Robert JH, Ris HB, Aubert JD. Survival impact of lung transplantation for COPD. Eur Respir J 2010;36(1):74-80.